1. Home
  2. EOLS vs PML Comparison

EOLS vs PML Comparison

Compare EOLS & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • PML
  • Stock Information
  • Founded
  • EOLS 2012
  • PML 2002
  • Country
  • EOLS United States
  • PML United States
  • Employees
  • EOLS N/A
  • PML N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • PML Investment Managers
  • Sector
  • EOLS Health Care
  • PML Finance
  • Exchange
  • EOLS Nasdaq
  • PML Nasdaq
  • Market Cap
  • EOLS 444.0M
  • PML 478.0M
  • IPO Year
  • EOLS 2018
  • PML N/A
  • Fundamental
  • Price
  • EOLS $7.03
  • PML $7.74
  • Analyst Decision
  • EOLS Strong Buy
  • PML
  • Analyst Count
  • EOLS 4
  • PML 0
  • Target Price
  • EOLS $21.25
  • PML N/A
  • AVG Volume (30 Days)
  • EOLS 2.0M
  • PML 188.0K
  • Earning Date
  • EOLS 11-05-2025
  • PML 01-01-0001
  • Dividend Yield
  • EOLS N/A
  • PML 5.65%
  • EPS Growth
  • EOLS N/A
  • PML N/A
  • EPS
  • EOLS N/A
  • PML N/A
  • Revenue
  • EOLS $285,823,000.00
  • PML N/A
  • Revenue This Year
  • EOLS $13.39
  • PML N/A
  • Revenue Next Year
  • EOLS $26.85
  • PML N/A
  • P/E Ratio
  • EOLS N/A
  • PML N/A
  • Revenue Growth
  • EOLS 15.10
  • PML N/A
  • 52 Week Low
  • EOLS $5.71
  • PML $6.92
  • 52 Week High
  • EOLS $17.12
  • PML $9.46
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 53.48
  • PML 39.33
  • Support Level
  • EOLS $6.53
  • PML $7.70
  • Resistance Level
  • EOLS $7.01
  • PML $7.77
  • Average True Range (ATR)
  • EOLS 0.41
  • PML 0.05
  • MACD
  • EOLS -0.01
  • PML -0.02
  • Stochastic Oscillator
  • EOLS 45.53
  • PML 19.15

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About PML Pimco Municipal Income Fund II of Beneficial Interest

PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.

Share on Social Networks: